IU Philanthropic Venture Fund returned for a series A round expected to help MBX identify clinical-stage peptides for rare endocrine genetic diseases.

GlaxoSmithKline is in line for an exit as CureVac files for an initial public offering in the US, 20 years after being spun out of Eberhard Karls University of Tübingen.

Indigo Diabetes increased its total funding to $52.6m with a series B round backed by Imec.xpand and returning investor Qbic.

AbbVie Ventures and Sofinnova Partners have co-led a series A round for Enthera Pharmaceuticals, which is using stem cells to treat autoimmune disorders.

The creative studio and 01Booster’s four-month joint venture will help grow the entrepreneurial ecosystem in the Japanese city of Fukushima and environs.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sidecar Health, which offers health insurance billed through a debit card, attracted Comcast Ventures to a round that brought its funding total to $40m.

Increasing both the number of shares and share price, iTeos Therapeutics has raised more than $201m in an offering that provided an exit to UCL and Ludwig Institute.

Nurix Therapeutics, a Celgene-backed cancer treatment developer based on UC Berkeley and San Francisco research, priced shares above its range to raise $209m.

Tubulis has raised series A funding to progress an ADC development platform invented at Leibniz Research Institute and Ludwig Maximillians University.